Altering β-cell number through stable alteration of miR-21 and miR-34a expression

References

• Donath MY, Størling J, Berchtold LA, Billestrup N, Mandrup-Poulsen T. Cytokines and beta-cell biology: from concept to clinical translation. Endocr Rev 2008; 29:334 - 50; http://dx.doi.org/10.1210/er.2007-0033; PMID: 18048762
   PubMed Web of Science ®Google Scholar
• Donath MY, Størling J, Maedler K, Mandrup-Poulsen T. Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. J Mol Med (Berl) 2003; 81:455 - 70; http://dx.doi.org/10.1007/s00109-003-0450-y; PMID: 12879149
   PubMed Web of Science ®Google Scholar
• Giannoukakis N, Rudert WA, Trucco M, Robbins PD. Protection of human islets from the effects of interleukin-1beta by adenoviral gene transfer of an Ikappa B repressor. J Biol Chem 2000; 275:36509 - 13; http://dx.doi.org/10.1074/jbc.M005943200; PMID: 10967112
   PubMed Web of Science ®Google Scholar
• Heimberg H, Heremans Y, Jobin C, Leemans R, Cardozo AK, Darville M, Eizirik DL. Inhibition of cytokine-induced NF-kappaB activation by adenovirus-mediated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis. Diabetes 2001; 50:2219 - 24; http://dx.doi.org/10.2337/diabetes.50.10.2219; PMID: 11574401
   PubMed Web of Science ®Google Scholar
• Larsen CM, Faulenbach M, Vaag A, Vølund A, Ehses JA, Seifert B, Mandrup-Poulsen T, Donath MY. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007; 356:1517 - 26; http://dx.doi.org/10.1056/NEJMoa065213; PMID: 17429083
   PubMed Web of Science ®Google Scholar
• Moran A, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, et al. Interleukin-1 antagonism in type one diabetes of recent onset: two multicentre, randomized, double-blind, placebo-controlled trials. Lancer 2013; 38:1905 - 15; http://dx.doi.org/10.1016/S0140-6736(13)60023-9
   Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281 - 97; http://dx.doi.org/10.1016/S0092-8674(04)00045-5; PMID: 14744438
   PubMed Web of Science ®Google Scholar
• Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19:92 - 105; http://dx.doi.org/10.1101/gr.082701.108; PMID: 18955434
   PubMed Web of Science ®Google Scholar
• Lynn FC, Skewes-Cox P, Kosaka Y, McManus MT, Harfe BD, German MS. MicroRNA expression is required for pancreatic islet cell genesis in the mouse. Diabetes 2007; 56:2938 - 45; http://dx.doi.org/10.2337/db07-0175; PMID: 17804764
   PubMed Web of Science ®Google Scholar
• Tang X, Tang G, Ozcan S. Role of microRNAs in diabetes. Biochim Biophys Acta 2008; 1779:697 - 701; http://dx.doi.org/10.1016/j.bbagrm.2008.06.010; PMID: 18655850
   PubMed Web of Science ®Google Scholar
• Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P, et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004; 432:226 - 30; http://dx.doi.org/10.1038/nature03076; PMID: 15538371
   PubMed Web of Science ®Google Scholar
• Lovis P, Roggli E, Laybutt DR, Gattesco S, Yang JY, Widmann C, Abderrahmani A, Regazzi R. Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction. Diabetes 2008; 57:2728 - 36; http://dx.doi.org/10.2337/db07-1252; PMID: 18633110
   PubMed Web of Science ®Google Scholar
• Roggli E, Britan A, Gattesco S, Lin-Marq N, Abderrahmani A, Meda P, Regazzi R. Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells. Diabetes 2010; 59:978 - 86; http://dx.doi.org/10.2337/db09-0881; PMID: 20086228
   PubMed Web of Science ®Google Scholar
• Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O’Leary JJ, Ruan Q, Johnson DS, Chen Y, O’Neill LA. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 2010; 11:141 - 7; http://dx.doi.org/10.1038/ni.1828; PMID: 19946272
   PubMed Web of Science ®Google Scholar
• Ruan Q, Wang T, Kameswaran V, Wei Q, Johnson DS, Matschinsky F, Shi W, Chen YH. The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic beta cell death. Proc Natl Acad Sci U S A 2011; 108:12030 - 5; http://dx.doi.org/10.1073/pnas.1101450108; PMID: 21730150
   PubMed Web of Science ®Google Scholar
• Zhou R, Hu G, Liu J, Gong AY, Drescher KM, Chen XM. NF-kappaB p65-dependent transactivation of miRNA genes following Cryptosporidium parvum infection stimulates epithelial cell immune responses. PLoS Pathog 2009; 5:e1000681; http://dx.doi.org/10.1371/journal.ppat.1000681; PMID: 19997496
   PubMed Web of Science ®Google Scholar
• Ma X, Buscaglia LEB, Barker JR, Li Y. MicroRNAs in NF-κB signaling. J Mol Cell Biol 2011; 0:1 - 8
   Google Scholar
• Ji Q, Hao X, Zhang M, Tang W, Yang M, Li L, Xiang D, Desano JT, Bommer GT, Fan D, et al. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One 2009; 4:e6816; http://dx.doi.org/10.1371/journal.pone.0006816; PMID: 19714243
   PubMed Web of Science ®Google Scholar
• Kasar S, Salerno E, Yuan Y, Underbayev C, Vollenweider D, Laurindo MF, Fernandes H, Bonci D, Addario A, Mazzella F, et al. Systemic in vivo lentiviral delivery of miR-15a/16 reduces malignancy in the NZB de novo mouse model of chronic lymphocytic leukemia. Genes Immun 2012; 13:109 - 19; http://dx.doi.org/10.1038/gene.2011.58; PMID: 21881595
   PubMed Web of Science ®Google Scholar
• Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005; 65:6029 - 33; http://dx.doi.org/10.1158/0008-5472.CAN-05-0137; PMID: 16024602
   PubMed Web of Science ®Google Scholar
• Krichevsky AM, Gabriely G. miR-21: a small multi-faceted RNA. J Cell Mol Med 2009; 13:39 - 53; http://dx.doi.org/10.1111/j.1582-4934.2008.00556.x; PMID: 19175699
   PubMed Web of Science ®Google Scholar
• Gaur AB, Holbeck SL, Colburn NH, Israel MA. Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo. Neuro Oncol 2011; 13:580 - 90; http://dx.doi.org/10.1093/neuonc/nor033; PMID: 21636706
   PubMed Web of Science ®Google Scholar
• Hu H, Li Y, Gu J, Zhu X, Dong D, Yao J, Lin C, Fei J. Antisense oligonucleotide against miR-21 inhibits migration and induces apoptosis in leukemic K562 cells. Leuk Lymphoma 2010; 51:694 - 701; http://dx.doi.org/10.3109/10428191003596835; PMID: 20141427
   PubMed Web of Science ®Google Scholar
• Park JK, Lee EJ, Esau C, Schmittgen TD. Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma. Pancreas 2009; 38:e190 - 9; http://dx.doi.org/10.1097/MPA.0b013e3181ba82e1; PMID: 19730150
   PubMed Web of Science ®Google Scholar
• Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133:647 - 58; http://dx.doi.org/10.1053/j.gastro.2007.05.022; PMID: 17681183
   PubMed Web of Science ®Google Scholar
• Zhu S, Si ML, Wu H, Mo YY. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 2007; 282:14328 - 36; http://dx.doi.org/10.1074/jbc.M611393200; PMID: 17363372
   PubMed Web of Science ®Google Scholar
• Selcuklu SD, Donoghue MT, Spillane C. miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans 2009; 37:918 - 25; http://dx.doi.org/10.1042/BST0370918; PMID: 19614619
   PubMed Web of Science ®Google Scholar
• Lu TX, Lim EJ, Itskovich S, Besse JA, Plassard AJ, Mingler MK, Rothenberg JA, Fulkerson PC, Aronow BJ, Rothenberg ME. Targeted ablation of miR-21 decreases murine eosinophil progenitor cell growth. PLoS One 2013; 8:e59397; http://dx.doi.org/10.1371/journal.pone.0059397; PMID: 23533623
   PubMedGoogle Scholar
• Li J, Huang H, Sun L, Yang M, Pan C, Chen W, Wu D, Lin Z, Zeng C, Yao Y, et al. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 2009; 15:3998 - 4008; http://dx.doi.org/10.1158/1078-0432.CCR-08-3053; PMID: 19509158
   PubMed Web of Science ®Google Scholar
• Papagiannakopoulos T, Shapiro A, Kosik KS. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 2008; 68:8164 - 72; http://dx.doi.org/10.1158/0008-5472.CAN-08-1305; PMID: 18829576
   PubMed Web of Science ®Google Scholar
• Cheng AM, Byrom MW, Shelton J, Ford LP. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 2005; 33:1290 - 7; http://dx.doi.org/10.1093/nar/gki200; PMID: 15741182
   PubMed Web of Science ®Google Scholar
• Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 2010; 39:493 - 506; http://dx.doi.org/10.1016/j.molcel.2010.07.023; PMID: 20797623
   PubMed Web of Science ®Google Scholar
• Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O’Leary JJ, Ruan Q, Johnson DS, Chen Y, O’Neill LA. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 2010; 11:141 - 7; http://dx.doi.org/10.1038/ni.1828; PMID: 19946272
   PubMed Web of Science ®Google Scholar
• Eto K, Goto S, Nakashima W, Ura Y, Abe SI. Loss of programmed cell death 4 induces apoptosis by promoting the translation of procaspase-3 mRNA. Cell Death Differ 2012; 19:573 - 81; http://dx.doi.org/10.1038/cdd.2011.126; PMID: 21959934
   PubMed Web of Science ®Google Scholar
• Novotny GW, Sonne SB, Nielsen JE, Jonstrup SP, Hansen MA, Skakkebaek NE, Rajpert-De Meyts E, Kjems J, Leffers H. Translational repression of E2F1 mRNA in carcinoma in situ and normal testis correlates with expression of the miR-17-92 cluster. Cell Death Differ 2007; 14:879 - 82; http://dx.doi.org/10.1038/sj.cdd.4402090; PMID: 17218954
   PubMed Web of Science ®Google Scholar
• Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren M. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007; 26:731 - 43; http://dx.doi.org/10.1016/j.molcel.2007.05.017; PMID: 17540598
   PubMed Web of Science ®Google Scholar
• Guo Y, Li S, Qu J, Wang S, Dang Y, Fan J, Yu S, Zhang J. MiR-34a inhibits lymphatic metastasis potential of mouse hepatoma cells. Mol Cell Biochem 2011; 354:275 - 82; http://dx.doi.org/10.1007/s11010-011-0827-0; PMID: 21553024
   PubMed Web of Science ®Google Scholar
• Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007; 26:745 - 52; http://dx.doi.org/10.1016/j.molcel.2007.05.010; PMID: 17540599
   PubMed Web of Science ®Google Scholar
• Li WB, Ma MW, Dong LJ, Wang F, Chen LX, Li XR. MicroRNA-34a targets notch1 and inhibits cell proliferation in glioblastoma multiforme. Cancer Biol Ther 2011; 12:477 - 83; http://dx.doi.org/10.4161/cbt.12.6.16300; PMID: 21743299
   PubMed Web of Science ®Google Scholar
• Welch C, Chen Y, Stallings RL. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 2007; 26:5017 - 22; http://dx.doi.org/10.1038/sj.onc.1210293; PMID: 17297439
   PubMed Web of Science ®Google Scholar
• Yamakuchi M, Ferlito M, Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci U S A 2008; 105:13421 - 6; http://dx.doi.org/10.1073/pnas.0801613105; PMID: 18755897
   PubMed Web of Science ®Google Scholar
• Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005; 434:113 - 8; http://dx.doi.org/10.1038/nature03354; PMID: 15744310
   PubMed Web of Science ®Google Scholar
• Moynihan KA, Grimm AA, Plueger MM, Bernal-Mizrachi E, Ford E, Cras-Méneur C, Permutt MA, Imai S. Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice. Cell Metab 2005; 2:105 - 17; http://dx.doi.org/10.1016/j.cmet.2005.07.001; PMID: 16098828
   PubMed Web of Science ®Google Scholar
• Biason-Lauber A, Böni-Schnetzler M, Hubbard BP, Bouzakri K, Brunner A, Cavelti-Weder C, Keller C, Meyer-Böni M, Meier DT, Brorsson C, et al. Identification of a SIRT1 mutation in a family with type 1 diabetes. Cell Metab 2013; 17:448 - 55; http://dx.doi.org/10.1016/j.cmet.2013.02.001; PMID: 23473037
   PubMed Web of Science ®Google Scholar
• Parnaud G, Bosco D, Berney T, Pattou F, Kerr-Conte J, Donath MY, Bruun C, Mandrup-Poulsen T, Billestrup N, Halban PA. Proliferation of sorted human and rat beta cells. Diabetologia 2008; 51:91 - 100; http://dx.doi.org/10.1007/s00125-007-0855-1; PMID: 17994216
   PubMed Web of Science ®Google Scholar
• Russ HA, Bar Y, Ravassard P, Efrat S. In vitro proliferation of cells derived from adult human beta-cells revealed by cell-lineage tracing. Diabetes 2008; 57:1575 - 83; http://dx.doi.org/10.2337/db07-1283; PMID: 18316362
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3:1101 - 8; http://dx.doi.org/10.1038/nprot.2008.73; PMID: 18546601
   PubMed Web of Science ®Google Scholar
• Schneider L, Clement CA, Teilmann SC, Pazour GJ, Hoffmann EK, Satir P, Christensen ST. PDGFRalphaalpha signaling is regulated through the primary cilium in fibroblasts. Curr Biol 2005; 15:1861 - 6; http://dx.doi.org/10.1016/j.cub.2005.09.012; PMID: 16243034
   PubMed Web of Science ®Google Scholar